Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 44,000 shares at $57.97 ($2.6M) on 2018-05-15, disclosed to the SEC on 2018-05-17.
Open-market sale of $2.6M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.97 | 43,000 | $2.5M | 97.7% |
| 2 | $58.73 | 1,000 | $59K | 2.3% |
| Total | $57.99 avg | 44,000 | $2.6M | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-09 | $6.1M | — | Filing → |